MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment

You might also be interested in ...

See all articles

press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
Research
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
Hilterapia @ Laser Therapy Summit, Egypt
News - 31/07/2026
ASA has concluded a scientific tour in Egypt focused on laser therapy, engaging universities, hospitals, private clinics, and healthcare institutions in Port Said, Cairo, and Suez.
Post-burn lesion on the lateral surface of the lower limb
Blog - 24/06/2026
Severe burns are one of the most complex conditions to address in clinical and rehabilitation settings. Beyond the initial tissue damage, the recovery process can be long and challenging,...
MLS Laser Therapy anti-inflammatory effect
Blog - 18/06/2026
Photobiomodulation (PBMT) is an evolving field of research, with growing interest towards its biological effects on tissues, particularly in modulating inflammatory processes. A recent experimental...